Literature DB >> 11044079

Role of murine leukemia virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in retroviral replication and in vivo fidelity.

E K Halvas1, E S Svarovskaia, V K Pathak.   

Abstract

Retroviral populations exhibit a high evolutionary potential, giving rise to extensive genetic variation. Error-prone DNA synthesis catalyzed by reverse transcriptase (RT) generates variation in retroviral populations. Structural features within RTs are likely to contribute to the high rate of errors that occur during reverse transcription. We sought to determine whether amino acids within murine leukemia virus (MLV) RT that contact the deoxyribonucleoside triphosphate (dNTP) substrate are important for in vivo fidelity of reverse transcription. We utilized the previously described ANGIE P encapsidating cell line, which expresses the amphotropic MLV envelope and a retroviral vector (pGA-1). pGA-1 expresses the bacterial beta-galactosidase gene (lacZ), which serves as a reporter of mutations. Extensive mutagenesis was performed on residues likely to interact with the dNTP substrate, and the effects of these mutations on the fidelity of reverse transcription were determined. As expected, most substitution mutations of amino acids that directly interact with the dNTP substrate significantly reduced viral titers (>10,000-fold), indicating that these residues played a critical role in catalysis and viral replication. However, the D153A and A154S substitutions, which are predicted to affect the interactions with the triphosphate, resulted in statistically significant increases in the mutation rate. In addition, the conservative substitution F155W, which may affect interactions with the base and the ribose, increased the mutation rate 2.8-fold. Substitutions of residues in the vicinity of the dNTP-binding site also resulted in statistically significant decreases in fidelity (1. 3- to 2.4-fold). These results suggest that mutations of residues that contact the substrate dNTP can affect viral replication as well as alter the fidelity of reverse transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044079      PMCID: PMC110909          DOI: 10.1128/jvi.74.22.10349-10358.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Reduced frameshift fidelity and processivity of HIV-1 reverse transcriptase mutants containing alanine substitutions in helix H of the thumb subdomain.

Authors:  K Bebenek; W A Beard; J R Casas-Finet; H R Kim; T A Darden; S H Wilson; T A Kunkel
Journal:  J Biol Chem       Date:  1995-08-18       Impact factor: 5.157

2.  Substrate binding domain of murine leukemia virus reverse transcriptase. Identification of lysine 103 and lysine 421 as binding site residues.

Authors:  A Basu; V B Nanduri; G F Gerard; M J Modak
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.

Authors:  S K Jang; H G Kräusslich; M J Nicklin; G M Duke; A C Palmenberg; E Wimmer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

4.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.

Authors:  J M Coffin
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

5.  Ouabain resistance conferred by expression of the cDNA for a murine Na+, K+-ATPase alpha subunit.

Authors:  R B Kent; J R Emanuel; Y Ben Neriah; R Levenson; D E Housman
Journal:  Science       Date:  1987-08-21       Impact factor: 47.728

6.  Analysis of the role of glutamine 190 in the catalytic mechanism of murine leukemia virus reverse transcriptase.

Authors:  J Jin; N Kaushik; K Singh; M J Modak
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

7.  Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.

Authors:  Z Gu; Q Gao; H Fang; H Salomon; M A Parniak; E Goldberg; J Cameron; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

8.  Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs.

Authors:  Z Gu; E J Arts; M A Parniak; M A Wainberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase.

Authors:  S G Sarafianos; V N Pandey; N Kaushik; M J Modak
Journal:  Biochemistry       Date:  1995-05-30       Impact factor: 3.162

10.  A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G-->A hypermutation during negative-strand viral DNA synthesis.

Authors:  A M Borman; C Quillent; P Charneau; K M Kean; F Clavel
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

View more
  13 in total

1.  Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching.

Authors:  C K Hwang; E S Svarovskaia; V K Pathak
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

2.  Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.

Authors:  Michael E Abram; Andrea L Ferris; Kalyan Das; Octavio Quinoñes; Wei Shao; Steven Tuske; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

3.  Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.

Authors:  Jean L Mbisa; Galina N Nikolenko; Vinay K Pathak
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

5.  The impact of molecular manipulation in residue 114 of human immunodeficiency virus type-1 reverse transcriptase on dNTP substrate binding and viral replication.

Authors:  Sarah K Van Cor-Hosmer; Waaqo Daddacha; Z Kelly; Amy Tsurumi; Edward M Kennedy; Baek Kim
Journal:  Virology       Date:  2011-12-05       Impact factor: 3.616

6.  The reverse transcriptase sequence of human immunodeficiency virus type 1 is under positive evolutionary selection within the central nervous system.

Authors:  Kelly J Huang; Gerald M Alter; Dawn P Wooley
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

7.  Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo.

Authors:  Wen-Hui Zhang; Carey K Hwang; Wei-Shau Hu; Robert J Gorelick; Vinay K Pathak
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts.

Authors:  Wen-Hui Zhang; Evguenia S Svarovskaia; Rebekah Barr; Vinay K Pathak
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

9.  Nucleotide specificity of HIV-1 reverse transcriptases with amino acid substitutions affecting Ala-114.

Authors:  Clara E Cases-González; Luis Menéndez-Arias
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

10.  Mutation rates and intrinsic fidelity of retroviral reverse transcriptases.

Authors:  Luis Menéndez-Arias
Journal:  Viruses       Date:  2009-12-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.